Your browser doesn't support javascript.
loading
Neuropeptide S receptor 1 is a nonhormonal treatment target in endometriosis.
Tapmeier, Thomas T; Rahmioglu, Nilufer; Lin, Jianghai; De Leo, Bianca; Obendorf, Maik; Raveendran, Muthuswamy; Fischer, Oliver M; Bafligil, Cemsel; Guo, Manman; Harris, Ronald Alan; Hess-Stumpp, Holger; Laux-Biehlmann, Alexis; Lowy, Ernesto; Lunter, Gerton; Malzahn, Jessica; Martin, Nicholas G; Martinez, Fernando O; Manek, Sanjiv; Mesch, Stefanie; Montgomery, Grant W; Morris, Andrew P; Nagel, Jens; Simmons, Heather A; Brocklebank, Denise; Shang, Catherine; Treloar, Susan; Wells, Graham; Becker, Christian M; Oppermann, Udo; Zollner, Thomas M; Kennedy, Stephen H; Kemnitz, Joseph W; Rogers, Jeffrey; Zondervan, Krina T.
Afiliación
  • Tapmeier TT; Oxford Endometriosis CaRe Centre, Nuffield Department of Women's & Reproductive Health, University of Oxford, Women's Centre, John Radcliffe Hospital, Oxford OX3 9DU, UK. thomas.tapmeier@monash.edu krina.zondervan@wrh.ox.ac.uk.
  • Rahmioglu N; Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria 3168, Australia.
  • Lin J; Oxford Endometriosis CaRe Centre, Nuffield Department of Women's & Reproductive Health, University of Oxford, Women's Centre, John Radcliffe Hospital, Oxford OX3 9DU, UK.
  • De Leo B; Wellcome Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.
  • Obendorf M; Oxford Endometriosis CaRe Centre, Nuffield Department of Women's & Reproductive Health, University of Oxford, Women's Centre, John Radcliffe Hospital, Oxford OX3 9DU, UK.
  • Raveendran M; Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University, Guangzhou, Guangdong 510632, PR China.
  • Fischer OM; Bayer AG Pharmaceuticals, Research & Development, Building S107, 13342 Berlin, Germany.
  • Bafligil C; Bayer AG Pharmaceuticals, Research & Development, Building S107, 13342 Berlin, Germany.
  • Guo M; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA.
  • Harris RA; Bayer AG Pharmaceuticals, Research & Development, Building S107, 13342 Berlin, Germany.
  • Hess-Stumpp H; Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Oxford OX3 7LD, UK.
  • Laux-Biehlmann A; Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Oxford OX3 7LD, UK.
  • Lowy E; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA.
  • Lunter G; Bayer AG Pharmaceuticals, Research & Development, Building S107, 13342 Berlin, Germany.
  • Malzahn J; Bayer AG Pharmaceuticals, Research & Development, Building S107, 13342 Berlin, Germany.
  • Martin NG; Wellcome Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.
  • Martinez FO; MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK.
  • Manek S; Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Oxford OX3 7LD, UK.
  • Mesch S; QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.
  • Montgomery GW; Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7YH, UK.
  • Morris AP; Department of Pathology, Oxford University Hospitals Foundation Trust, Oxford OX3 9DU, UK.
  • Nagel J; Bayer AG Pharmaceuticals, Research & Development, Building S107, 13342 Berlin, Germany.
  • Simmons HA; QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.
  • Brocklebank D; Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia.
  • Shang C; Wellcome Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.
  • Treloar S; Division of Musculoskeletal and Dermatological Sciences, University of Manchester, Manchester M13 9PL, UK.
  • Wells G; Bayer AG Pharmaceuticals, Research & Development, Building S107, 13342 Berlin, Germany.
  • Becker CM; Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA.
  • Oppermann U; Wellcome Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.
  • Zollner TM; Oxford Endometriosis CaRe Centre, Nuffield Department of Women's & Reproductive Health, University of Oxford, Women's Centre, John Radcliffe Hospital, Oxford OX3 9DU, UK.
  • Kennedy SH; QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.
  • Kemnitz JW; Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Oxford OX3 7LD, UK.
  • Rogers J; Oxford Endometriosis CaRe Centre, Nuffield Department of Women's & Reproductive Health, University of Oxford, Women's Centre, John Radcliffe Hospital, Oxford OX3 9DU, UK.
  • Zondervan KT; Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Oxford OX3 7LD, UK.
Sci Transl Med ; 13(608)2021 08 25.
Article en En | MEDLINE | ID: mdl-34433639
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Receptores Acoplados a Proteínas G / Endometriosis Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Sci Transl Med Asunto de la revista: CIENCIA / MEDICINA Año: 2021 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Receptores Acoplados a Proteínas G / Endometriosis Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Sci Transl Med Asunto de la revista: CIENCIA / MEDICINA Año: 2021 Tipo del documento: Article